Megan K. Levings

20.1k total citations · 5 hit papers
197 papers, 13.9k citations indexed

About

Megan K. Levings is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Megan K. Levings has authored 197 papers receiving a total of 13.9k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Immunology, 50 papers in Oncology and 30 papers in Genetics. Recurrent topics in Megan K. Levings's work include Immune Cell Function and Interaction (129 papers), T-cell and B-cell Immunology (123 papers) and Immunotherapy and Immune Responses (41 papers). Megan K. Levings is often cited by papers focused on Immune Cell Function and Interaction (129 papers), T-cell and B-cell Immunology (123 papers) and Immunotherapy and Immune Responses (41 papers). Megan K. Levings collaborates with scholars based in Canada, United States and Italy. Megan K. Levings's co-authors include Maria Grazia Roncarolo, Maria-Grazia Roncarolo, Rosa Bacchetta, Theodore S. Steiner, Silvia Gregori, Sarah Q. Crome, Natasha K. Crellin, Manuela Battaglia, Rosa V. Garcia and Raewyn Broady and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Megan K. Levings

191 papers receiving 13.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans

2006 931 citations Maria Grazia Roncarolo, Silvia Gregori et al. profile →
Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function

2001 814 citations Megan K. Levings et al. The Journal of Experimental Medicine profile →
Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production

2007 713 citations Theodore S. Steiner, Maria Grazia Roncarolo et al. profile →
Type 1 T regulatory cells

2001 654 citations Maria Grazia Roncarolo, Megan K. Levings et al. profile →
Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes

2021 211 citations Adam Ramzy, David Thompson et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Megan K. Levings Canada	60	10.4k	2.6k	1.9k	1.6k	1.2k	197	13.9k
Ciriaco A. Piccirillo Canada	54	9.5k 0.9×	2.1k 0.8×	1.9k 1.0×	1.7k 1.0×	1.2k 1.0×	145	13.2k
Jason D. Fontenot United States	23	14.3k 1.4×	2.5k 1.0×	2.0k 1.0×	1.4k 0.9×	1.3k 1.1×	39	17.0k
Tomoyuki Yamaguchi Japan	32	10.6k 1.0×	3.3k 1.3×	2.2k 1.1×	1.0k 0.6×	761 0.6×	84	14.6k
Wenda Gao United States	40	10.7k 1.0×	2.6k 1.0×	2.1k 1.1×	925 0.6×	1.3k 1.1×	95	15.1k
Christian Kurts Germany	66	9.7k 0.9×	2.1k 0.8×	3.4k 1.8×	1.1k 0.7×	1.7k 1.4×	196	14.9k
Rosanne Spolski United States	50	10.2k 1.0×	3.4k 1.3×	1.7k 0.9×	1.1k 0.7×	1.1k 0.9×	90	13.5k
Alf Hamann Germany	59	11.3k 1.1×	2.5k 0.9×	2.7k 1.4×	1.1k 0.7×	1.2k 1.0×	153	15.6k
Ananda W. Goldrath United States	60	13.2k 1.3×	3.9k 1.5×	3.7k 1.9×	999 0.6×	1.2k 1.0×	100	17.0k
Hans Acha‐Orbea Switzerland	55	9.5k 0.9×	1.6k 0.6×	2.0k 1.1×	2.2k 1.3×	1.3k 1.1×	172	13.2k
Marc A. Gavin United States	27	11.1k 1.1×	2.5k 0.9×	2.1k 1.1×	1.2k 0.7×	889 0.7×	45	13.7k

Countries citing papers authored by Megan K. Levings

Since Specialization

Citations

This map shows the geographic impact of Megan K. Levings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan K. Levings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan K. Levings more than expected).

Fields of papers citing papers by Megan K. Levings

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan K. Levings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan K. Levings. The network helps show where Megan K. Levings may publish in the future.

Co-authorship network of co-authors of Megan K. Levings

This figure shows the co-authorship network connecting the top 25 collaborators of Megan K. Levings. A scholar is included among the top collaborators of Megan K. Levings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan K. Levings. Megan K. Levings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wright, R Clay, Daniel Campbell, & Megan K. Levings. (2025). Pharmacotherapeutic strategies to promote regulatory T cell function in autoimmunity. Current Opinion in Immunology. 94. 102554–102554. 4 indexed citations

Martínez‐Bonet, Marta, Juan‐Miguel Gil‐Jaurena, Diana Hernández-Flórez, et al.. (2023). First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant. The Journal of Experimental Medicine. 220(12). 14 indexed citations

Ivison, Sabine, Qing Huang, Dhiraj Mannar, et al.. (2023). SARS-CoV-2 Variants Omicron BA.4/5 and XBB.1.5 Significantly Escape T Cell Recognition in Solid-organ Transplant Recipients Vaccinated Against the Ancestral Strain. Transplantation. 108(4). e49–e62. 1 indexed citations

Ellis, Cara E., Majid Mojibian, Shogo Ida, et al.. (2023). Human A2-CAR T Cells Reject HLA-A2+ Human Islets Transplanted Into Mice Without Inducing Graft-versus-host Disease. Transplantation. 107(9). e222–e233. 6 indexed citations

Levings, Megan K., et al.. (2023). Targeting regulatory T cell metabolism in disease: Novel therapeutic opportunities. European Journal of Immunology. 53(9). e2250002–e2250002. 9 indexed citations

Ivison, Sabine, et al.. (2023). T‐cell activation–induced marker assays in health and disease. Immunology and Cell Biology. 101(6). 491–503. 45 indexed citations

Spanier, Justin A., Vivian Fung, Yixin Chen, et al.. (2023). Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetes in mice. Journal of Clinical Investigation. 133(18). 33 indexed citations

Boardman, Dominic A., May Q. Wong, William D. Rees, et al.. (2022). Flagellin-specific human CAR Tregs for immune regulation in IBD. Journal of Autoimmunity. 134. 102961–102961. 29 indexed citations

Proïcs, Emma, Marion David, Majid Mojibian, et al.. (2022). Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation. Gene Therapy. 30(3-4). 309–322. 36 indexed citations

10.

Ahmad, Imran, Janet J. Bijl, Sabine Ivison, et al.. (2021). Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid- Refractory or Dependent Chronic GVHD – a Multicentre Phase II Clinical Trial (CARE Trial). Transplantation and Cellular Therapy. 27(3). S285–S285. 1 indexed citations

11.

Marwaha, Ashish, Anne M. Pesenacker, Laura Cook, et al.. (2021). A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes. PubMed. 2(1). ltab022–ltab022. 16 indexed citations

12.

Siren, Erika M. J., Lyann Sim, Qiunong Guan, et al.. (2021). Prevention of vascular-allograft rejection by protecting the endothelial glycocalyx with immunosuppressive polymers. Nature Biomedical Engineering. 5(10). 1202–1216. 18 indexed citations

13.

Cook, Laura, Shigeru Tanaka, Danielle J. Smyth, et al.. (2021). Induction of stable human FOXP3⁺ Tregs by a parasite‐derived TGF‐β mimic. Immunology and Cell Biology. 99(8). 833–847. 20 indexed citations

14.

Ramzy, Adam, David Thompson, Kirsten A. Ward‐Hartstonge, et al.. (2021). Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes. Cell stem cell. 28(12). 2047–2061.e5. 211 indexed citations breakdown →

15.

Wu, Dan, Chi Kin Wong, Jonathan M. Han, et al.. (2020). T reg–specific insulin receptor deletion prevents diet-induced and age-associated metabolic syndrome. The Journal of Experimental Medicine. 217(8). 31 indexed citations

16.

MacDonald, Katherine N., Anne M. Pesenacker, S. Juvet, et al.. (2019). Innate Control of Tissue-Reparative Human Regulatory T Cells. The Journal of Immunology. 202(8). 2195–2209. 36 indexed citations

17.

Pesenacker, Anne M., Adele Y. Wang, Amrit Singh, et al.. (2016). A Regulatory T-Cell Gene Signature Is a Specific and Sensitive Biomarker to Identify Children With New-Onset Type 1 Diabetes. Diabetes. 65(4). 1031–1039. 47 indexed citations

18.

Yu, Richard, Raewyn Broady, Yuanshen Huang, et al.. (2013). Correction: Transcriptome Analysis Reveals Markers of Aberrantly Activated Innate Immunity in Vitiligo Lesional and Non-Lesional Skin. PLoS ONE. 8(7). 4 indexed citations

19.

Patterson, Scott J., Jonathan M. Han, Rosa García, et al.. (2011). Cutting Edge: PHLPP Regulates the Development, Function, and Molecular Signaling Pathways of Regulatory T Cells. The Journal of Immunology. 186(10). 5533–5537. 58 indexed citations

20.

Roncarolo, Maria Grazia, Silvia Gregori, & Megan K. Levings. (2003). Type 1 T Regulatory Cells and Their Relationship with CD4 ⁺ CD25 ⁺ T Regulatory Cells. Novartis Foundation symposium. 252. 115–131. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact